Oppenheimer & Co. Inc. lifted its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 3.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 143,503 shares of the company’s stock after acquiring an additional 4,515 shares during the period. Oppenheimer & Co. Inc.’s holdings in Procter & Gamble were worth $20,565,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently made changes to their positions in the company. Triodos Investment Management BV lifted its holdings in Procter & Gamble by 7.3% in the third quarter. Triodos Investment Management BV now owns 255,095 shares of the company’s stock valued at $39,195,000 after acquiring an additional 17,400 shares during the period. Vanguard Group Inc. lifted its holdings in Procter & Gamble by 0.6% in the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock valued at $36,050,992,000 after acquiring an additional 1,419,322 shares during the period. Strengthening Families & Communities LLC lifted its holdings in Procter & Gamble by 820.6% in the third quarter. Strengthening Families & Communities LLC now owns 14,803 shares of the company’s stock valued at $2,308,000 after acquiring an additional 13,195 shares during the period. Heritage Wealth Management Inc. lifted its holdings in Procter & Gamble by 32.7% in the third quarter. Heritage Wealth Management Inc. now owns 150,814 shares of the company’s stock valued at $23,173,000 after acquiring an additional 37,198 shares during the period. Finally, Turtle Creek Wealth Advisors LLC lifted its holdings in Procter & Gamble by 21.5% in the third quarter. Turtle Creek Wealth Advisors LLC now owns 84,512 shares of the company’s stock valued at $12,985,000 after acquiring an additional 14,954 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Procter & Gamble news, insider Susan Street Whaley sold 1,809 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $159.46, for a total value of $288,463.14. Following the completion of the sale, the insider directly owned 30,215 shares in the company, valued at $4,818,083.90. This represents a 5.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary A. Coombe sold 36,093 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.33, for a total value of $5,858,976.69. Following the completion of the sale, the chief executive officer owned 34,994 shares of the company’s stock, valued at approximately $5,680,576.02. The trade was a 50.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 252,715 shares of company stock worth $40,966,904 over the last quarter. Corporate insiders own 0.20% of the company’s stock.
Key Stories Impacting Procter & Gamble
- Positive Sentiment: UBS raised its price target to $172 (from $166) and kept a Buy rating, highlighting continued confidence in P&G’s positioning among consumer staples — a clear positive for near-term investor sentiment. Procter & Gamble (PG): The Best Consumer Staples Stock to Invest In
- Positive Sentiment: TD Cowen raised its price recommendation to $150 (from $142) while maintaining a Hold — another incremental boost to investor outlook and a signal that some analysts see valuation upside. The Procter & Gamble Company (PG) – Among the 10 Best Large Cap Dividend Growth Stocks to Invest in
- Positive Sentiment: Procter & Gamble Health recorded a ₹32 crore gain from a Mumbai property sale — a small, one-time cash benefit that marginally supports local earnings/cash flow in India. Procter & Gamble Health Books ₹32 Crore Gain From Mumbai Property Sale
- Neutral Sentiment: New product/marketing activity: Gillette Venus launched the Smoothguard campaign targeting intimate grooming, a move toward younger, socially conscious consumers that supports medium-term category expansion but is unlikely to move near-term results materially. Venus Smoothguard Highlights P&G Push Into Targeted Grooming And Growth
- Negative Sentiment: Erste Group trimmed its FY2026 and FY2027 EPS forecasts (small downward revisions), and retains a Hold — analyst estimate cuts add pressure to sentiment and can cap upside if other shops follow.
- Negative Sentiment: P&G is reported to be under pressure from a Russell 1000 index rebalancing shift, which can create short-term selling flows as funds adjust holdings. Procter & Gamble Under Pressure In Russell 1000 Shift
Analyst Ratings Changes
PG has been the subject of a number of analyst reports. BNP Paribas Exane decreased their price target on Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating for the company in a report on Thursday, April 23rd. Evercore set a $162.00 target price on Procter & Gamble in a research note on Monday. Rothschild & Co Redburn reduced their target price on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research note on Monday. Morgan Stanley reduced their target price on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Finally, Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $161.06.
Read Our Latest Analysis on PG
Procter & Gamble Stock Up 0.6%
Shares of PG opened at $147.27 on Friday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73. The stock has a 50 day moving average price of $149.44 and a 200 day moving average price of $148.62. The stock has a market capitalization of $342.93 billion, a price-to-earnings ratio of 21.53, a PEG ratio of 6.27 and a beta of 0.41. Procter & Gamble Company has a one year low of $137.62 and a one year high of $170.99.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.03. The company had revenue of $21.24 billion during the quarter, compared to analysts’ expectations of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.92 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 24th will be issued a $1.0885 dividend. This represents a $4.35 annualized dividend and a yield of 3.0%. The ex-dividend date is Friday, April 24th. This is an increase from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s dividend payout ratio (DPR) is currently 63.60%.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
